Health Trials

Relapsed and/or Refractory Multiple Myeloma

2

Review clinical trials related to Relapsed and/or Refractory Multiple Myeloma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

The purpose of this study is to assess BMS-986453 in participants with relapsed and/or refractory multiple myeloma (RRMM).

Participants needed: 187
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyUpdated: Mar 18, 2026Locations: 19
Eligibility criteria

Participants must have a diagnosis of multiple myeloma with relapsed and/or refr... [+4]

Participants must not have any known active or history of central nervous system... [+3]

Read more
Status: Recruiting

OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM

An open label, dose exploratory clinical study to evaluate the safety, efficacy, and pharmacokinetics of OriCAR-017 in R/RMM

Participants needed: 83
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: OriCell Therapeutics Co., Ltd.Updated: May 31, 2024Locations: 5
Eligibility criteria

Diagnosis of R/RMM according to the IMWG criteria; [+7]

Smoldering myeloma (asymptomatic) [+13]

Read more